desidata
03-10-2008, 09:13 PM
Dear Members ,
Today we officially launched the DESIDATA PRIVATE PREMIUM service to our elite members , The main intention of the service is for web maintenance , honorary for admin , moderators and backend helpers , we are very happy as this is a real success and we proved our members that with first days call itself we gained one and half times our yearly subscription.
Today we have given calls on Intraday, Magic, Short term and Insider News
The reviews for the same are below
We advised our elite members to buy MOSERBAER for Intraday
MOSER BAER (BUY) 109-109.6 (Target1) 112 (Target 2) 115.7 (Sl) 104 (BUY 200 SHARES)
The stock reached the target in first hour of trade
112-109 = 3 X 100 = 300
115.7-112 = 3.7 x 100 = 370
Our members were profited 670 Rs in Intraday call
We advised SUZLON and ADHUNIK METALIKS as our Magic calls
SUZLON (BUY) 154-158 (Target1) 160-162 ( Target 2) 167 (Sl) 152 (TRADE IN 50 TO 100 STOCKS, DON'T GET PANICKED DURING TRADE. STOCK MY BLAST AT ANY TIME WITH BULK DEALS) (ONE CAN HOLD THE STOCK AND THE SHORT TERM TARGET OF 194)
The Stock reached the target one of 160
154 x 100 = 600
ADHUNIK METALIKS (BUY) 58.5-59.2 (Target1) 64 ( Target 2) 69 (Sl) 49 ( BUY 250 SHARES FOR TARGET IN 08-10 TRADING SESSIONS , MAINTAIN STRICT STOP LOSS)
The stock reached a high of 68.2 intraday and closed at 67 , if our members book profit at 67.5
67.5 – 58.5 = 9 x 250 = 1750
Our profits today
670 + 600 + 1750 = 3020 /-
( If members would have traded or invested according to our advice we had a profit of 3020 on day one which is one & half times our yearly subscription . check out the feedback written by one of our private premium members in feeback section )
Insider News – 01 Oct ( private premium members )
Major chunk of the instrumentation for the use of the nuclear technology will be with Siemens, a major benefit.
Patni computers had announced buy back upto 325 Rs and buying it from market from quite some below 200. their recent purchase been at 175 and 180 levels. Promoters are having merry time.
In case of UCO Bank, as per newspapers report, its equity capital is going to be reduced and when it is done, share can flare up sharply.
Capital Goods and Power stocks will lead the rally forward. Book profits in banking stocks on rally as banking stocks can come down from higher levels. Stocks like Larsen, Reliance Infra, Nagarjuna, Oswal Chemicals, Assam Company, NTPC, Power Grid, Reliance, Reliance Petro will outperform over short term.
Pfizer shifts focus to cancer and biotech drugsPfizer on Tuesday gave its semiannual update for investors on its research pipeline, stating that it now has 114 human studies of drugs in process and that the number of studies in the final stage has grown from 16 to 25 since its last update in March Biotechnology drugs, which generally are extremely profitable, will be a big part of that pipeline, particularly in cancer research.
Reliance ADA group has restarted talks over a potential buyout or equity investment in Metro-Goldwyn-Mayer, the New York Post reported.
With India receiving an NSG waiver, several homegrown firms have lined up investments worth Rs1,00,000 crore for foraying into nuclear power generation and are negotiating deals with companies from France.“Nuclear Power Corporation of India Ltd (NPCIL) has already done exploratory meetings and technical discussions with three global reactor suppliers including Areva of France.
One can join our service for a minimum subscription of 200/- per month , we can assure the best service , for more details check out announcements section or contact desidata@inbox.com
Admin
dD
Today we officially launched the DESIDATA PRIVATE PREMIUM service to our elite members , The main intention of the service is for web maintenance , honorary for admin , moderators and backend helpers , we are very happy as this is a real success and we proved our members that with first days call itself we gained one and half times our yearly subscription.
Today we have given calls on Intraday, Magic, Short term and Insider News
The reviews for the same are below
We advised our elite members to buy MOSERBAER for Intraday
MOSER BAER (BUY) 109-109.6 (Target1) 112 (Target 2) 115.7 (Sl) 104 (BUY 200 SHARES)
The stock reached the target in first hour of trade
112-109 = 3 X 100 = 300
115.7-112 = 3.7 x 100 = 370
Our members were profited 670 Rs in Intraday call
We advised SUZLON and ADHUNIK METALIKS as our Magic calls
SUZLON (BUY) 154-158 (Target1) 160-162 ( Target 2) 167 (Sl) 152 (TRADE IN 50 TO 100 STOCKS, DON'T GET PANICKED DURING TRADE. STOCK MY BLAST AT ANY TIME WITH BULK DEALS) (ONE CAN HOLD THE STOCK AND THE SHORT TERM TARGET OF 194)
The Stock reached the target one of 160
154 x 100 = 600
ADHUNIK METALIKS (BUY) 58.5-59.2 (Target1) 64 ( Target 2) 69 (Sl) 49 ( BUY 250 SHARES FOR TARGET IN 08-10 TRADING SESSIONS , MAINTAIN STRICT STOP LOSS)
The stock reached a high of 68.2 intraday and closed at 67 , if our members book profit at 67.5
67.5 – 58.5 = 9 x 250 = 1750
Our profits today
670 + 600 + 1750 = 3020 /-
( If members would have traded or invested according to our advice we had a profit of 3020 on day one which is one & half times our yearly subscription . check out the feedback written by one of our private premium members in feeback section )
Insider News – 01 Oct ( private premium members )
Major chunk of the instrumentation for the use of the nuclear technology will be with Siemens, a major benefit.
Patni computers had announced buy back upto 325 Rs and buying it from market from quite some below 200. their recent purchase been at 175 and 180 levels. Promoters are having merry time.
In case of UCO Bank, as per newspapers report, its equity capital is going to be reduced and when it is done, share can flare up sharply.
Capital Goods and Power stocks will lead the rally forward. Book profits in banking stocks on rally as banking stocks can come down from higher levels. Stocks like Larsen, Reliance Infra, Nagarjuna, Oswal Chemicals, Assam Company, NTPC, Power Grid, Reliance, Reliance Petro will outperform over short term.
Pfizer shifts focus to cancer and biotech drugsPfizer on Tuesday gave its semiannual update for investors on its research pipeline, stating that it now has 114 human studies of drugs in process and that the number of studies in the final stage has grown from 16 to 25 since its last update in March Biotechnology drugs, which generally are extremely profitable, will be a big part of that pipeline, particularly in cancer research.
Reliance ADA group has restarted talks over a potential buyout or equity investment in Metro-Goldwyn-Mayer, the New York Post reported.
With India receiving an NSG waiver, several homegrown firms have lined up investments worth Rs1,00,000 crore for foraying into nuclear power generation and are negotiating deals with companies from France.“Nuclear Power Corporation of India Ltd (NPCIL) has already done exploratory meetings and technical discussions with three global reactor suppliers including Areva of France.
One can join our service for a minimum subscription of 200/- per month , we can assure the best service , for more details check out announcements section or contact desidata@inbox.com
Admin
dD